) minerals are essential for many physiologic processes. 1 Ca 2ϩ plays a pathologic role in osteoporosis, nephrolithiasis, vascular calcification, nephrocalcinosis, and chronic kidney disease, and disturbances in Mg 2ϩ contribute to muscle cramps, paraesthesia, convulsions, arrhythmias, and cardiac arrest. Their overall mineral balance is regulated by the concerted actions of kidneys, intestine, and bone. 2 The kidneys determine the final excretion of these cations and fulfills, and therefore, an important step in homeostatic control. This role was recognized by Homer Smith, who wrote "…Little is known concerning Ca 2ϩ excretion except that the total excretion can be increased or decreased by a variety of circumstances. Much that has been said about Ca 2ϩ applies to Mg 2ϩ . The mechanism by which renal excretion of Mg 2ϩ is controlled is unknown…" 3 In the last decade, considerable progress has been made in elucidating the molecular mechanisms underlying the reabsorption of these minerals by the kidney. Instrumental in this respect are studies of rare monogenic diseases related to defective renal Mg 2ϩ handling and genetically modified mice with deleted Ca 2ϩ transport proteins. 4, 5 These studies identified new transport proteins and have led to the development of new concepts for the renal handling of minerals.
IMPORTANCE OF THE DISTAL PART OF THE NEPHRON
Active reabsorption of Mg 2ϩ and Ca 2ϩ takes place in the distal part of the nephron only. More precisely, this part of the nephron is comprised of the distal convoluted tubule (DCT) and the connecting tubule (CNT) leading to the collecting duct. 6 The former can be further subdivided into early (DCT1) and late (DCT2) segments. Based on micropuncture experiments and the conspicuous localization of transport proteins, active Mg 2ϩ transport is confined to the DCT1 and DCT2 segments, whereas active Ca 2ϩ reabsorption mainly occurs along the DCT2 and CNT segments ( Figure 1 ). 1 Thus, DCT2 functions as a transition area between Mg 2ϩ and Ca 2ϩ reabsorption.
Mg 2؉ REABSORPTION IN DCT1 AND DCT2 SEGMENTS
The DCT is famous for the presence of the thiazide-sensitive NaCl co-transporter (NCC) along the luminal membrane, which is energized by a Na ϩ gradient generated by the basolateral Na ϩ -K ϩ -ATPase. 7, 8 Active transcellular Mg 2ϩ transport along the DCT is envisaged by the following sequential steps (Figure 2 The apical epithelial Mg 2ϩ channel is known as the transient receptor potential melastatin, subtype 6 (TRPM6). TRPM6 is a cation channel composed of six transmembrane-spanning domains and a conserved pore-forming region that assembles in a tetrameric configuration. Studies of families with autosomal recessive hypomagnesemia with secondary hypocalcemia identified mutations in TRPM6. 10, 11 TRPM6 is one of eight members of the identified TRPM cation channel subfamily and is composed of 2022 amino acids encoded by a large gene containing 39 exons. 10 -12 TRPM6 displays a restricted expression pattern and is predominantly present in reabsorbing epithelia. 10, 11, 13 In the kidney, TRPM6 localizes along the apical membrane of the DCT. 13 This channel is a unique bifunctional protein consisting of an Mg 2ϩ permeable cation channel with protein kinase activity and is occasionally referred to as chanzymes. 14 Electrophysiologic characterization of TRPM6 shows that TRPM6-transfected human embryonic kidney 293 cells exhibit outwardly rectifying currents. Mg 2ϩ itself has a profound effect on the activity of TRPM6. For instance, intracellular Mg 2ϩ levels tightly regulate TRPM6 activity with an apparent K i of 0.5 mM that is comparable to physiologic intracellular Mg 2ϩ concentrations. 13 16 The phenotype detectable from infancy consists of recurrent muscle cramps, tetany, tremor, muscle weakness, cerebellar at- ϩ -K ϩ -ATPase, situated in the basolateral membrane, provides a sodium (Na ϩ ) gradient that is used by the thiazide-sensitive NCC to facilitate transport of Na ϩ from the tubular fluid into the cytoplasm and a K ϩ gradient to generate local membrane potential. K ϩ is supplied to the Na ϩ -K ϩ -ATPase through recycling through Kir4.1. The ␥-subunit of the Na ϩ -K ϩ -ATPase regulates the function of Na ϩ pump. Transcription factor HNF1B (hepatocyte nuclear factor 1 homeobox B) regulates the expression of the ␥-subunit of the Na ϩ -K ϩ -ATPase. EGF is the first magnesiotropic hormone to regulate active Mg 2ϩ reabsorption through the TRPM6 channel.
rophy, and myokymia. The K ϩ channel co-localizes with TRPM6 along the luminal membrane of the DCT. The identified mutation results in a nonfunctional channel with a dominant-negative effect on wild-type channel function. 17 Thus, Kv1.1 is a new luminal K ϩ channel in the DCT that establishes favorable luminal membrane potential controlling TRPM6-mediated Mg 2ϩ reabsorption.
We also identified FXYD2 as being involved in hypomagnesemia. 18 FXYD2 encodes the ␥-subunit of the basolateral Na ϩ -K ϩ -ATPase and is mutated in patients with autosomal dominant renal hypomagnesemia associated with hypocalciuria. Currently, the exact molecular mechanism by which the ␥-subunit controls Mg 2ϩ handling in the DCT remains elusive. It is postulated this transmembrane protein facilitates the basolateral extrusion of Mg 2ϩ in renal epithelial cells. 19 Others suggest the ␥-subunit regulates additional transport mechanisms that localize to the basolateral membrane such as the Na Further support for an active role of the ␥-subunit in Mg 2ϩ reabsorption is suggested by the observation that a transcription factor, hepatocyte nuclear factor 1B (HNF1B), modulates the FXYD2 gene. 20 Hypomagnesemia, hypermagnesuria, and hypocalciuria are observed in one half of the HNF1B mutation carriers. Analyses of the FXYD2 promoter region identify two highly conserved HNF1B recognition sites. Future studies should confirm the role of HNF1B in the regulation of FXYD2 and possibly other components of the molecular machinery involved in renal Mg 2ϩ handling.
Kir4.1
Two independent studies recently described a mutation within the KCNJ10 gene as the underlying cause of a hypomagnesemia syndrome. 21, 22 The first study described two nonrelated consanguineous families with a disorder characterized by epilepsy, ataxia, sensorineurol deafness, and tubulopathy (also referred to as SeSAME), whereas the other study 
EGF
We identified EGF as the first magnesiotropic hormone directly stimulating TRPM6 activity. 23 Genetic analyses showed that a point mutation in the pro-EGF gene causes a rare inherited autosomal recessive form of renal hypomagnesemia. EGF acts as an autocrine/paracrine magnesiotropic hormone, specifically increasing TRPM6 activity by engagement of its receptor along the basolateral membrane of DCT cells. This activation relies on both the Src family of tyrosine kinases and the downstream effector, Rac1. Activation of Rac1 increases the mobility of TRPM6, assessed by fluorescence recovery after photobleaching, and a constitutively active mutant of Rac1 mimics the stimulatory effect of EGF on TRPM6 mobility and activity. Ultimately, TRPM6 activation results from increased cell surface abundance. 24 These findings provide the first insight into the molecular regulation of TRPM6 by extracellular EGF. Moreover, it shows the molecular basis for the hypomagnesemia after treatment with cetuximab, an EGF receptor blocking antibody used in the treatment of colorectal cancer, and indicates TRPM6 is a potential pharmacologic target during cetuximab therapy. 23 (Figure 3) . Ca 2ϩ influx across the apical membrane is mediated by TRPV5. Subsequently, the specialized intracellular carrier protein, calbindin-D28K, sequesters Ca 2ϩ entering the cell, and this complex diffuses toward the basolateral membrane. Finally, transporter proteins, such as NCX1 and PMCA1b, extrude Ca 2ϩ from the epithelial cell back into the circulation. 2 Apical Entry of Ca 2؉ by TRPV5
To identify the apical Ca 2ϩ influx channel involved in transcellular Ca 2ϩ reabsorption, we performed functional expression cloning using a cDNA library from rabbit primary CNT and the cortical collecting duct. 27 Injection of total mRNA from this isolation into Xenopus laevis oocytes induces a 45 Ca 2ϩ uptake two to three times above background. Subsequently, the entire cDNA library was screened for 45 Ca 2ϩ uptake, and a single transcript was isolated that encodes for a novel epithelial Ca 2ϩ channel called eCaC1 and later renamed TRPV5, as a member of the TRP channel superfamily. 27, 28 This channel comprises intracellular amino and carboxyl-terminal tails flanking six transmembrane domains and an additional hydrophobic stretch between domains 5 and 6, predicted to be the pore-forming region. Furthermore, the first extracellular loop between transmembrane domains 1 and 2 contains an evolutionary conserved asparagine (N 358 ) crucial for its complexglycosylation, and in turn, for regulating channel activity. 29 -31 The carboxyl and amino-terminal tails contain several regulatory sites including protein kinase C and A sites, which suggests an important role for phosphorylation in the regulation of channel activity. Moreover, in cultured mammalian cells, as well as in oocytes, TRPV5 assembles into homotetramers to acquire an active conformational state. 29, 32 The TRPV5-null (TRPV Ϫ/Ϫ ) mouse provides compelling evidence for the physiologic function of this channel. Active Ca 2ϩ reabsorption in DCT2 and CNT segments is severely impaired in these null animals, because TRPV5 Ϫ/Ϫ mice excrete ϳ10-fold more Ca 2ϩ than their wild-type littermates, in line with a postulated gatekeeper function for TRPV5 in active Ca 2ϩ reabsorption. 33 Electrophysiologic studies showed constitutive activity of TRPV5 at low intracellular Ca 2ϩ concentrations and physiologic membrane potentials. 34 The current-voltage relationship of TRPV5 shows strong inward rectification. 2, 34 Another important functional feature is that TRPV5 is the most Ca 2ϩ -selective member of the TRP superfamily. 34 The single channel conductance, P o , and the number of channels at the plasma membrane determines cellular TRPV5 activity. This activity is under the control of various factors like hormones, intracellular Ca 2ϩ , and other intracellular messengers.
Vitamin D
Ample evidence of a direct role for vitamin D in the positive regulation of TRPV5 comes from several animal studies, particularly those involving 25-hydroxyvitamin D 3 -1␣-hydroxylase-and vitamin D receptor-null mice. 35, 36 A direct relationship between 1,25(OH) 2 D 3 -induced expression of Ca 2ϩ transport proteins and transcellular Ca 2ϩ transport is known from studies of cultured cells from DCT and CNT cells. 37, 38 Together these studies suggest a consistent 1,25(OH) 2 D 3 sensitivity of TRPV5 and the calbindins, and, to a lesser extent, the basolateral extrusion systems involving NCX1, a Na ϩ /Ca 2ϩ exchanger, and PMCA1b, a plasma membrane Ca 2ϩ -ATPase.
Thiazide Diuretics
Thiazide diuretics, in contrast to loop diuretics, have the unique characteristic of decreasing Na ϩ reabsorption while increasing Ca 2ϩ reabsorption. In addition, mutations in the NCC gene encoding the NaCl co-transporter cause Gitelman's syndrome. Patients with Gitelman's syndrome exhibit hypovolemia, hypokalemic alkalosis, hypomagnesemia, and hypocalciuria. 39 Intriguingly, the molecular mechanisms responsible for the hypocalciuria and hypomagnesemia with thiazide administration or in Gitelman's syndrome remain elusive. Two hypotheses exist with respect to the Ca SPECIAL ARTICLE www.jasn.org zides. 40, 41 First, renal salt and water loss caused by thiazide treatment results in contraction of the extracellular volume (ECV), which triggers a compensatory increase of proximal Na ϩ reabsorption. This in turn enhances the electrochemical gradient driving passive Ca 2ϩ transport in proximal tubular segments. 6, 39, 42 Second, thiazide treatment stimulates Ca 2ϩ reabsorption in DCT, possibly through the TRPV5 channel, that could explain the Ca 2ϩ -sparing effect. 40 We showed in rats that hydrochlorothiazide-induced hypocalciuria is accompanied by a significant decrease in body weight compared with controls, confirming ECV contraction. 43, 44 Because sodium depletion results in a similar hypocalciuria, it is likely that the ECV contraction by itself is responsible for the thiazide-induced hypocalciuria. Further evidence supporting this notion is the finding that sodium repletion during thiazide treatment, thereby preventing the ECV contraction, normalizes the calciuresis. A direct role for TRPV5 in the thiazide-induced hypocalciuria seems unlikely, because thiazides also have a hypocalciuric effect in TRPV5 Ϫ/Ϫ mice, and the overlap in the expression of NCC and TRPV5 in the distal part of the nephron is restricted to DCT2. 44 Taken together, enhanced proximal tubular Na ϩ transport as a consequence of ECV contraction stimulates paracellular Ca 2ϩ transport and best explains the tubular mechanism for thiazideinduced hypocalciuria.
Activation of the Ca 2؉ -Sensing Receptor Prevents Nephrolithiasis

TRPV5
Ϫ/Ϫ mice display hypercalciuria from impaired active Ca 2ϩ reabsorption but also hyperphosphaturia, polyuria, and increased urinary acidification. 33 The latter two adaptations seem highly beneficial because there are no renal calcium precipitates. Polyuria also diminishes the risk of renal stone formation by reducing urinary Ca 2ϩ concentration. In mice, calciuresis linearly correlates with urinary volume because an increase in Ca 2ϩ excretion leads to an enhanced urinary volume. The consistent polyuria in hypercalciuric TRPV5 Ϫ/Ϫ mice, noted by a substantial decrease in urinary osmolality, is caused by downregulation of renal AQP2 water channels, possibly a result of activating the Ca 2ϩ -sensing receptor along the luminal membrane of the collecting duct. 45 Figure 4 . Molecular mechanism of Ca 2ϩ -induced polyuria and urinary acidification. The Ca 2ϩ -sensing receptor (CaSR) is localized at the apical site of principal and intercalated cells of the collecting duct. AQP2 proteins are responsible for water reabsorption, whereas H ϩ -ATPases pump H ϩ into the tubular fluid. During hypercalciuria, increased urinary Ca 2ϩ levels activate the CaSR. CaSR activation leads to AQP2 downregulation and polyuria. Furthermore, the CaSR triggers urinary acidification by increasing the H ϩ -ATPase activity. Both polyuria and increased urinary acidification prevent the precipitation of renal Ca 2ϩ -phosphate.
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